-Ikuo Sekine Researcher Activity Profile

Research Author Detailed Information 

Ikuo Sekine Publication Rate By Year

Ikuo Sekine has published 11 paper(s) in 2007, 2 paper(s) in 2008, for a total of 13 research publications in total.

Ikuo I Sekine Author Information

LAST NAME: sekine

FIRST NAME: ikuo

INITIALS: I

AFFILIATION:

Papers

Ikuo Sekine's Publication Record

1. A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with lung cancer. Year Published: 2007
Divisions of Thoracic Oncology and Internal Medicine, National Cancer Center Hospital, Tokyo, Japan.
2. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
3. Phase I study of cisplatin analogue nedaplatin, paclitaxel, and thoracic radiotherapy for unresectable stage III non-small cell lung cancer. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp
4. Serum total bilirubin as a predictive factor for severe neutropenia in lung cancer patients treated with cisplatin and irinotecan. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan.
5. Genes regulating the sensitivity of solid tumor cell lines to cytotoxic agents: a literature review. Year Published: 2007
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. isekine@ncc.go.jp
6. Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung. Year Published: 2007
Divisions of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan.
7. Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Year Published: 2007
Division of Internal Medicine, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
8. Epidermal growth factor receptor mutation detection using high-resolution melting analysis predicts outcomes in patients with advanced non small cell lung cancer treated with gefitinib. Year Published: 2007
Division of Internal Medicine, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
9. Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences.
10. Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
11. Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese population. Year Published: 2007
Project Team for Pharmacogenetics, National Institute of Health Sciences, Tokyo, Japan.
12. Influence of Previous Chemotherapy on the Efficacy of Subsequent Docetaxel Therapy in Advanced Non-small Cell Lung Cancer Patients. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
13. Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients. Year Published: 2008
Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.